ANEST IWATA (6381) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
6 Jun, 2025Executive summary
Net sales rose 1.8% year-over-year to 54,411 million yen, driven by sales recovery in Japan and strong coating equipment sales in Europe, but operating profit declined to 5,903 million yen and net income attributable to owners dropped 13.3% to 4,276 million yen.
ROE declined to 9.4% (down 2.3 pts), while the equity ratio improved to 67.7% (up 0.9 pts).
Year-end dividend set at 23 yen per share, 5 yen below initial forecast; annual dividend totals 45 yen, with a planned increase to 83 yen for the next fiscal year.
Cash and cash equivalents increased by 3,077 million yen to 17,686 million yen at year-end.
Financial highlights
Net sales: 54,411 million yen (+1.8% year-over-year); operating profit: 5,903 million yen (−0.7% to −4.4% year-over-year); net income attributable to owners: 4,276 million yen (−13.3% year-over-year).
Ordinary profit: 7,139 million yen (−10.6% year-over-year); comprehensive income fell 18.9% to 6,627 million yen.
Operating cash flow surged 44.0% year-over-year to 9,746 million yen; investing cash outflows increased to 3,255 million yen, and financing cash outflows rose to 3,932 million yen.
Foreign exchange gains of 21 million yen, down 718 million yen year-over-year.
Annual dividend per share decreased by 4 yen to 45 yen.
Outlook and guidance
FY2025 net sales targeted at 58,000 million yen (+6.6% year-over-year); operating profit expected to decline 6.0% to 5,550 million yen; net income attributable to owners forecast at 4,150 million yen (−3.0%).
Revenue growth expected in all regions, with focus on air compressors in Japan and India and coating equipment in Europe and the US.
Profit decline anticipated due to higher personnel expenses and aggressive investments in new businesses and IT.
Annual dividend for FY2025 forecast at 83 yen per share; share buybacks planned during the new Medium-Term Business Plan.
Focus remains on overseas market expansion, M&A, and diversified investments under the new Medium-Term Business Plan.
Latest events from ANEST IWATA
- Profits and sales fell, but financial stability and full-year guidance were maintained.6381
Q3 202610 Feb 2026 - Sales and profit fell, but FX gains and cash flow stability kept guidance unchanged.6381
Q2 202628 Nov 2025 - Q1 sales and profits declined, comprehensive income turned negative, but guidance is unchanged.6381
Q1 20268 Aug 2025 - Sales rose but profits fell on margin and forex pressures; outlook and dividend steady.6381
Q2 202413 Jun 2025 - Sales rose but profits fell on higher costs; full-year outlook maintained amid global risks.6381
Q1 202513 Jun 2025 - Profit outlook cut as China lags and costs rise, but investment and R&D remain on track.6381
Q3 20255 Jun 2025